alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Kyle Bolstad

514 Americas Way #2894

Box Elder, SD 57719

773.837.2288

kyle@bolstad.com

February 12, 2016

Petition for Section 333 Exemption

I hereby formally request FAA authorization for Kyle Bolstad (hereafter “PETITIONER”) to operate a 

UAS for civil (non-governmental) purposes other than for hobby or recreation.

PETITIONER requests exemption from 14 CFR §§ 61.23(a) and (c), 61.101(e)(4) and (5), 61.113(a), 

61.315(a), 91.7(a), 91.119(c), 91.121, 91.151(a)(1), 91.405(a), 91.407(a)(1), 91.409(a)(1) and (2), and 

91.417(a) and (b), to the extent necessary to allow PETITIONER to operate a UAS to perform aerial data 

collection, including but not limited to aerial imaging.

PETITIONER requests this permission to pursue its use of UAS models with a DJI Phantom 3 

(Registration #FA3CYE4PNH).

PETITIONER requests this exemption for its use of UAS both within and without the United States. 

PETITIONER frequently travels abroad for photographic endeavors and seeks to use UAS in accordance 

with all laws of foreign and domestic governmental authorities.

PETITIONER’s use of the UAS will be done in a manner which will minimize the risk to the NAS, other 

persons and spectators, and property. The following procedures will assist in minimizing impact: (1) 

UAS will be given a pre-flight inspection before each flight to examine air-worthiness, (2) UAS will not 

be materially altered from commercial specifications except for battery, prop, and other minor alterations, 

(3) UAS will not be flown over people, (4) UAS will always be flown within line of sight to operator(s) 

pursuant to Section 333(b)(1), (5) UAS will never reach altitudes over exceeding those allowed, (6) UAS 

will never exceed speeds of 50 miles per hour, (7) operator will perform a visual inspection of the NAS to 

locate nearby hazards before taking flight, (8) UAS will be checked for flight stability, proper connection 

to remote control, and proper performance at a very low altitude before reaching the NAS, and (9) 

spectators will be asked to stay a safe distance away from the flight path of the UAS and its landing 

location. PETITIONER has a Sport Pilot Certificate (#3518242) and has over two years of experience 

with flying an unmanned aircraft system for personal use.

This petition will benefit the public interest. PETITIONER plans to provide previously inaccessible aerial 

photography of scenery and real estate for local residents.

Kyle Bolstad
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED STATEMENTS OF EARNINGS AND CONSOLIDATED BALANCE SHEETS
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                         410,875
<SECURITIES>                                 2,353,427
<RECEIVABLES>                                  485,259
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,434,440
<PP&E>                                         131,459
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               4,225,834
<CURRENT-LIABILITIES>                        2,182,864
<BONDS>                                        300,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           706
<OTHER-SE>                                   1,314,517
<TOTAL-LIABILITY-AND-EQUITY>                 4,225,834
<SALES>                                              0
<TOTAL-REVENUES>                             6,478,350
<CGS>                                                0
<TOTAL-COSTS>                                6,031,522
<OTHER-EXPENSES>                                27,939
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              26,903
<INCOME-PRETAX>                                391,986
<INCOME-TAX>                                    72,438
<INCOME-CONTINUING>                            319,548
<DISCONTINUED>                                (88,268)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   231,280
<EPS-PRIMARY>                                     3.35
<EPS-DILUTED>                                     3.29
        

</TABLE>
[Federal Register Volume 89, Number 21 (Wednesday, January 31, 2024)]
[Notices]
[Page 6121]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01847]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive and 
Kidney Diseases Special Emphasis Panel; HIV Comorbidities.
    Date: March 25, 2024.
    Time: 11:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK, Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Elena Sanovich, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7351, 
6707 Democracy Boulevard, Bethesda, MD 20892-2542, 301-594-8886, 
<a href="/cdn-cgi/l/email-protection#c8bba9a6a7bea1aba0ad88a5a9a1a4e6a6a1a0e6afa7be"><span class="__cf_email__" data-cfemail="a6d5c7c8c9d0cfc5cec3e6cbc7cfca88c8cfce88c1c9d0">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: January 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01847 Filed 1-30-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
II

104TH CONGRESS

2D SESSION S. 2080

To save taxpayer money by reducing the unnecessary increase in Pentagon

spending in fiscal year 1997.

IN THE SENATE OF THE UNITED STATES

SEPTEMBER 17, 1996

Mr. HARKIN introduced the following bill; which was read twice and referred

to the Committee on Armed Services

A BILL

To save taxpayer money by reducing the unnecessary

increase in Pentagon spending in fiscal year 1997.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. REDUCTION OF UNNECESSARY INCREASE IN

4 PENTAGON SPENDING.

5 (a) LIMITATION.—Notwithstanding any other provi6 sion of law, the total amount authorized to be appro7 priated by the National Defense Authorization Act for Fis8 cal Year 1997 may not exceed the amount requested by

9 the President for fiscal year 1997 for the national security

10 activities of the Department of Defense and the Depart-
2

•S 2080 IS

1 ment of Energy in the budget submitted to Congress by

2 the President for that fiscal year under section 1105 of

3 title 31, United States Code.

4 (b) ALLOCATION OF REDUCTIONS.—The Secretary of

5 Defense shall allocate reductions in authorizations of ap6 propriations that are necessary as a result of the applica7 tion of the limitation set forth in subsection (a) so as not

8 to jeopardize the military readiness of the Armed Forces

9 or the quality of life of Armed Forces personnel.

10 (c) EXCESS AUTHORIZATIONS TO BE USED FOR

11 DEFICIT REDUCTION.—The reduction under subsection

12 (a) of the total amount that, except for that subsection,

13 would otherwise be authorized to be appropriated for fiscal

14 year 1997 by the Act referred to in that subsection shall

15 be applied to reduce the budget deficit for fiscal year

16 1997.

Æ
<PAGE>

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
            SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as
chief financial officer of SMTC Corporation (the "Company"), does hereby certify
that to the undersigned's knowledge:

     3) the Company's quarterly report on Form 10-Q for the quarter ended
        September 29, 2002 fully complies with the requirements of Section 13(a)
        or 15(d) of the Securities Exchange Act of 1934; and

     4) the information contained in the Company's quarterly report on Form 10-Q
        for the quarter ended September 29, 2002 fairly presents, in all
        material respects, the financial condition and results of operations of
        the Company.

                            /s/ Frank Burke
                            ------------------------
                            Frank Burke
                            Chief Financial Officer

Dated: November 13, 2002
**EXHIBIT 32.01**

 

**CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEFFINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTEDPURSUANT TO SECTION 906 OF**

**THE SARBANES-OXLEY ACT OF 2002**

 

I,Robert L. Howard-Anderson, certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, thatthe Quarterly Report of Occam Networks, Inc. on Form 10-Q for thefiscal quarter ended June 30, 2010 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934,as amended and that information contained in such Quarterly Report onForm 10-Q fairly presents in all material respects the financial conditionand results of operations of Occam Networks, Inc.

 
| Date: July 30, 2010 | By:    | /s/ ROBERT L.  HOWARD-ANDERSON         |
|--------------------------|--------|----------------------------------------|
|                     | Name:  | Robert L. Howard-Anderson              |
|                     | Title: | President and Chief  Executive Officer |
|                     |   | (Principal Executive  Officer)         |

 

I,Jeanne Seeley, certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that theQuarterly Report of Occam Networks, Inc. on Form 10-Q for the fiscalquarter ended June 30, 2010 fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934,as amended and that information contained in such Quarterly Report onForm 10-Q fairly presents in all material respects the financial conditionand results of operations of Occam Networks, Inc.

 
| Date: July 30, 2010 | By:    | /s/ JEANNE SEELEY                                  |
|--------------------------|--------|----------------------------------------------------|
|                     | Name:  | Jeanne Seeley                                      |
|                     | Title: | Senior Vice President and  Chief Financial Officer |
|                     |   | (Principal Financial and  Accounting Officer)      |

 

Asigned original of this written statement required by Section 906 has beenprovided to Occam Networks, Inc. and will be retained by OccamNetworks, Inc. and furnished to the Securities and Exchange Commission orits staff upon request.

 

----
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                       1,228,208
<SECURITIES>                                         0
<RECEIVABLES>                                  479,125
<ALLOWANCES>                                  (33,251)
<INVENTORY>                                  1,527,338
<CURRENT-ASSETS>                             3,310,713
<PP&E>                                       1,048,027
<DEPRECIATION>                               (206,391)
<TOTAL-ASSETS>                               5,193,103
<CURRENT-LIABILITIES>                        1,708,777
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  1,102,500
<COMMON>                                     6,870,624
<OTHER-SE>                                 (5,044,025)
<TOTAL-LIABILITY-AND-EQUITY>                 5,193,103
<SALES>                                      7,328,601
<TOTAL-REVENUES>                             7,530,661
<CGS>                                        5,895,661
<TOTAL-COSTS>                                4,196,143
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                33,251
<INTEREST-EXPENSE>                             139,081
<INCOME-PRETAX>                            (2,561,213)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,561,213)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,561,213)
<EPS-PRIMARY>                                   (0.41)
<EPS-DILUTED>                                   (0.41)
        

</TABLE>
<PAGE>   1
                                                                    EXHIBIT 23.1



                       CONSENT OF INDEPENDENT ACCOUNTANTS
                       ----------------------------------


        We hereby consent to the incorporation by reference in the Prospectus
constituting part of the Registration Statement on Form S-8 of Trimedyne, Inc.
of our report dated December 24, 1996 appearing on page F-2 of this Form 10-K.
We also consent to the reference to us under the heading "Experts" in such
Prospectus.


PRICE WATERHOUSE LLP
Costa Mesa, California
December 27, 1996
<PAGE>

                                                                    EXHIBIT 11.0

                          COMPUTATION OF PER SHARE LOSS

LOSS PER SHARE

     We adopted Statement of Financial Accounting Standards ("SFAS") No. 128 for
the fiscal year ended March 31, 1998. SFAS No. 128 replaces the presentation of
primary and fully diluted loss per share with a presentation of basic earnings
per share and diluted loss per share, if dilutive shares are outstanding. Basic
loss per share excludes dilution and is computed by dividing income or loss
available to common stockholders by the weighted-average number of common shares
outstanding for the period. Diluted loss per share reflects the potential
dilution that could occur if securities or other contracts to issue common stock
were converted into common stock, but such securities or contracts are excluded
if their effects would be anti-dilutive. Pursuant to the requirements of Staff
Accounting Bulletin ("SAB") No. 98 of the Securities and Exchange Commission,
issued in February 1998, common equivalent shares which have an anti-dilutive
effect on net loss per share are no longer included in computing net loss per
share for the periods presented. All prior-period loss per share data has been
restated in accordance with SFAS No. 128 and SAB No. 98.

     Basic loss per common share was calculated by dividing net loss by the
weighted average number of common shares outstanding during the period. Diluted
loss per share was calculated the same as basic loss per share since we have a
net loss for all periods presented which would make the conversion of securities
or other contracts to common stock anti-dilutive.

<TABLE>
<CAPTION>

                                                                     YEAR ENDED
                                                                      MARCH 31
                                                                 2001          2000
                                                             ----------      ---------

          <S>                                               <C>            <C>
           Net Loss                                          (11,503,217)   (10,140,118)

           Loss per common share - basic & diluted              (1.11)         (1.13)

           Number of common shares - basic & diluted          10,371,343      8,948,488

</TABLE>




                                       53
Exhibit 10.61


AMENDMENT

TO

ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK


Pursuant
to Section 9(a) of the Warrant to Purchase Common Stock of (the “Warrant”) of Actinium Pharmaceuticals, Inc.
(the “Company”), dated January 31, 2012, issued to Sandesh Seth in the amount of 64,746 warrant shares, the
Board of Directors of the Company has duly adopted a resolution approving this Amendment to the Warrant to extend the term of
the Warrant to February 11, 2022 as follows:


1.      
Section 1 of the Warrant is hereby amended to read in its entirety as follows:


“Term
of Warrant. Subject to the terms and conditions set forth herein, this Warrant shall be exercisable, in whole or in part,
during the term commencing (“Issuance Date”) January 31, 2012 (the “Warrant Issue Date”),
and ending at 5:00 p.m., Eastern Time on February 11, 2022 and shall be void thereafter.”


2.      
All other terms and provisions of the Warrant shall remain unchanged and in full force and effect as written.


IN
WITNESS WHEREOF, this Amendment to the Warrant is made effective this 14th day of March, 2017.


 


	 	ACTINIUM PHARMACEUTICALS, INC.
	 	 	 
	 	By:	/s/
    Kaushik J. Dave
	 	Name:	Kaushik J. Dave
	 	Title:	Chief Executive officer
<PAGE>

                                                                    EXHIBIT 99.2

                         TIMCO AVIATION SERVICES, INC.
                                 623 Radar Road
                             Greensboro, N.C. 27410



April 19, 2002

United States Securities and Exchange Commission
450 Fifth Street, N.W.
Judiciary Plaza
Washington, D.C.  20549

Ladies and Gentlemen:

Arthur Andersen LLP has represented to TIMCO Aviation Services, Inc. that its
audit was subject to Andersen's quality control system for the U.S. accounting
and auditing practice to provide reasonable assurance that the engagement was
conducted in compliance with professional standards and that there was
appropriate continuity of Andersen personnel working on the audit, availability
of national office consultation and availability of personnel at affiliates of
Andersen to conduct the relevant portions of the audit.

Sincerely,

TIMCO Aviation Services, Inc.

By:    /s/  C. ROBERT CAMPBELL
      -----------------------------------
       C. Robert Campbell
       Executive Vice President &
       Chief Financial Officer
<PAGE>

                                                                     EXHIBIT 21

                        WELLPOINT HEALTH NETWORKS INC.
                             LIST OF SUBSIDIARIES


                                                                   STATE OF 
CORPORATION                                                        INCORPORATION

BC Life & Health Insurance Company                                 California
Blue Cross of California                                           California
Comprehensive Integrated Marketing Services                        California
Cost Care, Inc.                                                    Massachusetts
National Capital Health Plan, Inc.                                 Virginia
UNICARE National Capital Preferred Provider Organization, Inc.     Maryland
Professional Claim Services, Inc.                                  New York
UNICARE Life & Health Insurance Company                            Delaware
UNICARE National Services, Inc.                                    Delaware
UNICARE of Texas Health Plans, Inc.                                Texas
UNICARE Specialty Services, Inc.                                   Delaware
WellPoint Behavioral Health, Inc.                                  Delaware
WellPoint California Services, Inc.                                Delaware
WellPoint Development Company, Inc.                                Delaware
EXHIBIT 99.5



Statement



Pursuant to §906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. §1350, the undersigned officer of WTA Inc. (the
Company), hereby certifies that to his knowledge:



(1)  the Companys Quarterly Report on Form 10-Q for the period ended March 30, 2003 fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities
Exchange Act of 1934, and



(2)  the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                    |  | WTA INC.             
|------------------- |  | ---------------------
|                   
|Dated: May 12, 2003 |  | /S/    DALE E.
PARKER
|                    |  | Name:                
|                    |  | Title:               



This certification
accompanies this Quarterly Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of the Securities Exchange Act of 1934. A signed original of this written statement
required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
**Exhibit
      32.2**





**CERTIFICATION
      PURSUANT TO**


**18
      USC. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the quarterly report on Form 10-Q/A of Interstate Data USA,
      Inc.
      (the “Company”) for the three and six months ended June 30, 2008 as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      Duane James, Vice President of Finance of the Company, hereby certify, pursuant
      to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
      2002, that:




(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.




October
                20, 2008
            
            /S/Duane
                JamesDuane
                James
              Vice
                President of Finance
              (Principal
                Financial Officer and
              Principal
                Accounting Officer)